Market Trends of Total Ankle Replacement Industry
Hintegra Total Ankle Replacement Segment Expects to Register a Significant Growth Over the Forecast Period
Total ankle replacement, a form of ankle arthroplasty or joint replacement surgery, involves prosthetics being used to replace the damaged parts of the ankle. The Hintegra prosthesis is a non-constrained three-component system made up of a mobile bearing consisting of ultra-high molecular weight polyethylene, a talar component, and a tibial component that provides axial rotation and normal flexion-extension mobility.
The Hintegra total ankle replacement segment is expected to witness significant growth in the studied market over the forecast period owing to factors such as increasing adoption of ankle replacement surgery as a treatment option for various ankle-related issues such as ankle chronic pain, ankle arthritis, end-stage ankle osteoarthritis, and others and the high preference of these devices and the surging aging population.
Total ankle replacement (TAR), which offers better results, has taken the lead in the management of end-stage ankle osteoarthritis. For instance, according to a report published by the Journal of Bone and Joint Surgery in May 2022, the long-term survival of patients with Hintegra implant was assessed and it has been observed that the cumulative survival rate was 95% at 5 years, 86% at 10 years and 82% at 15 years. The high survival rate of the Hintegra total ankle replacement design is expected to fuel its adoption for treating ankle fractures, hence propelling market growth.
Therefore, with the rising number of research studies to evaluate the effectiveness of Hintegra among the population suffering from ankle injuries, the studied market is anticipated to grow over the forecast period
North America is Expected to Hold Significant Market Share Over the Forecast Period
North America is expected to hold a significant share in the total ankle replacement market and show the same trend over the forecast period owing to factors such as the rising prevalence of rheumatoid arthritis and osteoarthritis, high awareness among the people regarding ankle treatment, presence of well-established healthcare infrastructure, availability of reimbursements, and increased healthcare spending in the region.
The rising burden of joint-related disorders such as rheumatoid arthritis, osteoporosis, and osteoarthritis among the population, especially the elderly, owing to their weak bones, is expected to increase market growth. For instance, according to the data published by Osteoporosis Canada 2022 Facts and Figures, it was observed that about 2.3 million people were living with osteoporosis in Canada in 2022, and about 80% of all fractures in people aged 50 years and above are caused by osteoporosis. Also, according to the 2022 statistics published by the CDC, about 62% of the women living in the United States suffered from osteoarthritis in 2021. In addition, as per the same source, about 78 million United States adults are expected to suffer from arthritis by 2040. This raises the risk of developing ankle osteoarthritis and osteoporosis due to inflamed tissue in the ankle and weak bones, respectively, hence expected to augment the market growth in the region over the forecast period.
Additionally, the application of artificial intelligence (AI) and robotics in numerous orthopedic surgery subspecialties, such as foot and ankle surgery, has rapidly increased. For instance, according to an article published in Sensors in January 2023, the United States researchers observed that using robots in foot and ankle surgery has also made it possible to gain a greater understanding of ankle mechanics with implications for bettering therapy and post-operative results. As per the same source, developing an image-guided robotic assistant to improve tibial and fibular reduction in ankle fractures involving injury to the distal syndesmosis enhances reduction accuracy with decreased need for surgeon intervention and repeated fluoroscopy exposure. Hence, the introduction of machine learning and new technologies in ankle fracture diagnosis and replacement surgeries are expected to fuel its adoption. This is anticipated to propel the market growth over the forecast period.
Furthermore, the rising new product launches and approvals increase the availability of advanced ankle replacement products in the market, which is expected to fuel the market growth in the region over the forecast period. For instance, in December 2022, Enovis received the United States FDA approval for the STAR Patient Specific Instrumentation (STAR PSI System) for use with the company’s STAR total ankle replacement system. The system provides a personalized pre-operative plan for each patient. The STAR PSI System is utilized with an updated and simplified surgical technique, which has the potential to reduce operative time during total ankle replacement cases. Also, in April 2023, the Food and Drug Administration approved restor3d’s first all-metal patient-specific instrument (PSI), Axiom PSR, in ankle arthroplasty. This launch assists the company in providing more customized surgeries, which are primarily aided by advancements in 3D printing, to patients with ankle replacements.
Therefore, owing to factors such as the increasing burden of orthopedic disorders, the rising application of artificial intelligence and robotics in surgeries, and new product approvals, the studied market is expected to grow over the forecast period.
